Investing.com - Amicus reported on Monday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Amicus announced earnings per share of $-0.120 on revenue of $81.69M. Analysts polled by Investing.com anticipated EPS of $-0.189 on revenue of $84.33M.
Amicus shares are down 28% from the beginning of the year and are trading at $9.875 , down-from-52-week-high.
Amicus shares lost 2.32% in intra-day trade after the report.
Amicus follows other major Healthcare sector earnings this month
Amicus's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar